Radiopharm Theranostics Limited Cash And Cash Equivalents
Radiopharm Theranostics Limited (RADX) had Cash And Cash Equivalents of $29.12 million as of 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-09-18
- 2025-06-30: Cash And Cash Equivalents $29.12M.
- 2024-06-30: Cash And Cash Equivalents $18.58M.
- 2023-06-30: Cash And Cash Equivalents $11.70M.
- 2022-06-30: Cash And Cash Equivalents $26.98M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-06-30 | $29.12M 20-F · filed 2025-09-18 |
| 2024-06-30 | $18.58M 20-F · filed 2025-09-18 |
| 2023-06-30 | $11.70M 20-F · filed 2025-09-18 |
| 2022-06-30 | $26.98M 20-F · filed 2025-09-18 |